1. Hennequin, L. F. A.; Ple, P.; Stokes, E. S. E.; McKerrecher, D. Preparation of quinazoline derivatives as angiogenesis inhibitors; WO2000047212A1 [139:164806].
2. AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
3. Arnott, E. A.; Crosby, J.; Evans, M.
C.; Ford, J.
G.; Jones, M.
F.; Leslie, K.
W.; McFarlane, I. M.; Sependa, G. J. Process for preparation of 4-fluoro-2-methyl-1H-indol-5-ol from fluorohalonitrobenzenes and acetoacetate esters; WO2008053221A2, [148:517536].
4. XLV. Theory of ætherification
5. bFeuer, H.; Hooz, J. In The Chemistry of the Ether Linkage; Patai, S., Ed. Wiley: New York, 1967; pp 448–450 and 460–468.